IDEAS home Printed from https://ideas.repec.org/e/pep15.html
   My authors  Follow this author

David Mark Epstein

Personal Details

First Name:David
Middle Name:Mark
Last Name:Epstein
Suffix:
RePEc Short-ID:pep15
[This author has chosen not to make the email address public]
http://www.ugr.es/davidepstein
University of Granada Department of Applied Economics

Affiliation

Departamento de Economía Aplicada
Facultad de Ciencias Económicas y Empresariales
Universidad de Granada

Granada, Spain
http://www.ugr.es/~ecoapli/
RePEc:edi:daugres (more details at EDIRC)

Research output

as
Jump to: Working papers Articles

Working papers

  1. David Epstein, 2016. "Health Related Quality of Life after Surgical Repair of Asymptomatic Abdominal Aortic Aneurysms," FEG Working Paper Series 02/16, Faculty of Economics and Business (University of Granada).
  2. David Epstein & Sarah Onida & Roshan Bootun & Marta Ortega-Ortega & Alun Davies, 2016. "Effectiveness of treatments of varicose veins. Systematic review and evidence synthesis," FEG Working Paper Series 01/16, Faculty of Economics and Business (University of Granada).
  3. David Epstein & Dolores Jimenez-Rubio & Peter C Smith & Marc Suhrcke, 2009. "An economic framework for analysing the social determinants of health and health inequalities," Working Papers 052cherp, Centre for Health Economics, University of York.
  4. Claire McKenna & Zaid Chalabi & David Epstein & Karl Claxton, 2008. "Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions," Working Papers 044cherp, Centre for Health Economics, University of York.

Articles

  1. Daniel Pérez-Troncoso & David M. Epstein & José A. Castañeda-García, 2021. "Consumers' Preferences and Willingness to Pay for Personalised Nutrition," Applied Health Economics and Health Policy, Springer, vol. 19(5), pages 757-767, September.
  2. Zuzana Špacírová & David Epstein & Leticia García-Mochón & Joan Rovira & Antonio Olry de Labry Lima & Jaime Espín, 2020. "A general framework for classifying costing methods for economic evaluation of health care," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(4), pages 529-542, June.
  3. David Epstein, 2019. "Beyond the cost‐effectiveness acceptability curve: The appropriateness of rank probabilities for presenting the results of economic evaluation in multiple technology appraisal," Health Economics, John Wiley & Sons, Ltd., vol. 28(6), pages 801-807, June.
  4. Claire Rothery & Karl Claxton & Stephen Palmer & David Epstein & Rosanna Tarricone & Mark Sculpher, 2017. "Characterising Uncertainty in the Assessment of Medical Devices and Determining Future Research Needs," Health Economics, John Wiley & Sons, Ltd., vol. 26(S1), pages 109-123, February.
  5. Edmund Jones & David Epstein & Leticia García-Mochón, 2017. "A Procedure for Deriving Formulas to Convert Transition Rates to Probabilities for Multistate Markov Models," Medical Decision Making, , vol. 37(7), pages 779-789, October.
  6. David Epstein & Leticia García-Mochón & Stephen Kaptoge & Simon G. Thompson, 2016. "Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(8), pages 1041-1053, November.
  7. David Epstein & Antonio Olry Labry Lima & Leticia García Mochón & Jaime Espín Balbino & Javier Esquivias, 2014. "A comparison of the accuracy of liquid cytology versus conventional screening: a meta-analysis of split-sample studies," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 177(1), pages 153-168, January.
  8. David Epstein, 2014. "Comment On ‘Heterogeneity In Action: The Role Of Passive Personalization In Comparative Effectiveness Research’," Health Economics, John Wiley & Sons, Ltd., vol. 23(3), pages 374-375, March.
  9. Rita Faria & Manuel Gomes & David Epstein & Ian White, 2014. "A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials," PharmacoEconomics, Springer, vol. 32(12), pages 1157-1170, December.
  10. David Epstein & Leticia García Mochón & Jaime Espín & Marta O. Soares, 2013. "Use of Multiparameter Evidence Synthesis to Assess the Appropriateness of Data and Structure in Decision Models," Medical Decision Making, , vol. 33(5), pages 715-730, July.
  11. Huiqin Yang & Dawn Craig & David Epstein & Laura Bojke & Kate Light & Ian Bruce & Mark Sculpher & Nerys Woolacott, 2012. "Golimumab for the Treatment of Psoriatic Arthritis," PharmacoEconomics, Springer, vol. 30(4), pages 257-270, April.
  12. McKenna, Claire & Chalabi, Zaid & Epstein, David & Claxton, Karl, 2010. "Budgetary policies and available actions: A generalisation of decision rules for allocation and research decisions," Journal of Health Economics, Elsevier, vol. 29(1), pages 170-181, January.
  13. David Epstein & Dolores Jiménez‐Rubio & Peter C. Smith & Marc Suhrcke, 2009. "Social determinants of health: an economic perspective," Health Economics, John Wiley & Sons, Ltd., vol. 18(5), pages 495-502, May.
  14. David Epstein & Anne Mason & Andrea Manca, 2008. "The hospital costs of care for stroke in nine European countries," Health Economics, John Wiley & Sons, Ltd., vol. 17(S1), pages 21-31, January.
  15. Chalabi, Zaid & Epstein, David & McKenna, Claire & Claxton, Karl, 2008. "Uncertainty and value of information when allocating resources within and between healthcare programmes," European Journal of Operational Research, Elsevier, vol. 191(2), pages 530-539, December.
  16. David M. Epstein & Zaid Chalabi & Karl Claxton & Mark Sculpher, 2007. "Efficiency, Equity, and Budgetary Policies," Medical Decision Making, , vol. 27(2), pages 128-137, March.
  17. David Epstein & Anne Mason, 2006. "Costs and prices for inpatient care in England: Mirror twins or distant cousins?," Health Care Management Science, Springer, vol. 9(3), pages 233-242, August.
  18. Neil Hawkins & David Epstein & Michael Drummond & Jennifer Wilby & Anita Kainth & David Chadwick & Mark Sculpher, 2005. "Assessing the Cost-Effectiveness of New Pharmaceuticals in Epilepsy in Adults: The Results of a Probabilistic Decision Model," Medical Decision Making, , vol. 25(5), pages 493-510, September.
  19. Neil Hawkins & Mark Sculpher & David Epstein, 2005. "Cost-Effectiveness Analysis of Treatments for Chronic Disease: Using R to Incorporate Time Dependency of Treatment Response," Medical Decision Making, , vol. 25(5), pages 511-519, September.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 2 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-HEA: Health Economics (2) 2009-11-07 2016-12-18

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, David Mark Epstein should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.